Consolidated Statement of Operations - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
Details
Revenues	$ 3,798,149	$ 3,715,767	$ 11,088,397	$ 10,731,096
Operating expenses:
Cost of revenues	2,137,662	3,908,281	6,206,428	8,173,702
Research and development expenses	143,102	151,185	426,376	455,014
Selling, general, and administrative expenses	2,411,029	2,254,846	7,079,287	6,751,959
Operating Expenses	4,691,793	6,314,312	13,712,091	15,380,675
Loss from operations	(893,644)	(2,598,545)	(2,623,694)	(4,649,579)
Interest expense - related party	180,191	78,300	515,875	214,100
Other loss	0	0	0	4,506
Loss before income taxes	(1,073,835)	(2,676,845)	(3,139,569)	(4,868,185)
Provision for income taxes	0	0	0	0
Net loss	$ (1,073,835)	$ (2,676,845)	$ (3,139,569)	$ (4,868,185)
Net loss per common share - basic	$ (0.14)	$ (0.35)	$ (0.41)	$ (0.63)
Net loss per common share - diluted	$ (0.14)	$ (0.35)	$ (0.41)	$ (0.63)
Weighted average number of common shares outstanding - basic	7,696,091	7,696,091	7,696,091	7,696,091
Weighted average number of common shares outstanding - diluted	7,696,091	7,696,091	7,696,091	7,696,091